Related Experiment Video

Updated: Aug 19, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancer

Donald P McDonnell1

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA. donald.mcdonnell@duke.edu

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|February 11, 2005
PubMed

Insights

Estrogens impact reproductive cancers and signaling pathways. This review details estrogen receptor pharmacology to guide drug selection and identify new therapeutic targets for estrogen-linked disorders.

Area of Science:

  • Endocrinology and Molecular Pharmacology
  • Oncology
  • Pharmacology

Background:

  • Estrogens exert significant physiological effects across multiple systems, including reproductive, skeletal, and central nervous systems.
  • Aberrant estrogen activity is implicated in the proliferation of breast and reproductive tract cancers.
  • Pharmaceuticals targeting the estrogen signaling pathway are crucial in managing various estrogen-dependent conditions.

Purpose of the Study:

  • To review the molecular pharmacology of the estrogen receptor.
  • To guide the selection of therapeutic drugs based on estrogen receptor knowledge.
  • To identify novel pharmaceutical targets for treating estrogen-linked diseases.

Main Methods:

  • Literature review of molecular pharmacology of estrogen receptor.
  • Analysis of estrogen signal transduction pathways.
  • Identification of therapeutic strategies and drug targets.

Main Results:

  • Detailed overview of estrogen receptor molecular mechanisms.
  • Discussion on how receptor pharmacology informs drug choice.
  • Identification of potential new targets for pharmaceutical intervention.

Conclusions:

  • Understanding estrogen receptor molecular pharmacology is key to effective drug selection.
  • This knowledge can lead to the development of novel therapeutics for estrogen-related cancers and disorders.
  • Further research into new targets promises advanced pharmaceutical applications.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: